Loss of ARHGEF1 causes a human primary antibody deficiency
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
ARHGEF1 is a RhoA-specific guanine nucleotide exchange factor expressed in hematopoietic cells. We used whole-exome sequencing to identify compound heterozygous mutations in ARHGEF1, resulting in the loss of ARHGEF1 protein expression in 2 primary antibody-deficient siblings presenting with recurrent severe respiratory tract infections and bronchiectasis. Both ARHGEF1-deficient patients showed an abnormal B cell immunophenotype, with a deficiency in marginal zone and memory B cells and an increased frequency of transitional B cells. Furthermore, the patients' blood contained immature myeloid cells. Analysis of a mediastinal lymph node from one patient highlighted the small size of the germinal centers and an abnormally high plasma cell content. On the molecular level, T and B lymphocytes from both patients displayed low RhoA activity and low steady-state actin polymerization (even after stimulation of lysophospholipid receptors). As a consequence of disturbed regulation of the RhoA downstream target Rho-associated kinase I/II (ROCK), the patients' lymphocytes failed to efficiently restrain AKT phosphorylation. Enforced ARHGEF1 expression or drug-induced activation of RhoA in the patients' cells corrected the impaired actin polymerization and AKT regulation. Our results indicate that ARHGEF1 activity in human lymphocytes is involved in controlling actin cytoskeleton dynamics, restraining PI3K/AKT signaling, and confining B lymphocytes and myelocytes within their dedicated functional environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1
Schmidt, G., Sehr, P., Wilm, M., Selzer, J., Mann, M., & Aktories, K. (1997) · Nature · doi:10.1038/42735 · Cited by 530
An update on the biology of sphingosine 1-phosphate receptors
Blaho, V. A., & Hla, T. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046300 · Cited by 516
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections
Dobbs, K., Domínguez Conde, C., Zhang, S.-Y., Parolini, S., Audry, M., Chou, J., Haapaniemi, E., Keles, S., Bilic, I., Okada, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413462 · Cited by 201
Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV infections
Crequer, A., Troeger, A., Patin, E., Ma, C. S., Picard, C., Pedergnana, V., Fieschi, C., Lim, A., Abhyankar, A., Gineau, L., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62949 · Cited by 159
Jaiswal, M., Gremer, L., Dvorsky, R., Haeusler, L. C., Cirstea, I. C., Uhlenbrock, K., & Ahmadian, M. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226431 · Cited by 68
Cited by
Tangye, S. G., Al-Herz, W., Bousfiha, A., Chatila, T., Cunningham-Rundles, C., Etzioni, A., Franco, J. L., Holland, S. M., Klein, C., Morio, T., et al. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00737-x · Cited by 1,210
Self-citationRhoA as a Key Regulator of Innate and Adaptive Immunity
Bros, M., Haas, K., Moll, L., & Grabbe, S. (2019) · Cells · doi:10.3390/cells8070733 · Cited by 193
“Recently, Bouafia and co-workers demonstrated that an inherited loss-of-function mutation of RhoA-specific ARHGEF1 in human was the cause for elevated frequencies of transitional B cells, accompanied by a lack of splenic marginal zone B cells and memory B cells [229].”
RHO GTPases: from new partners to complex immune syndromes
El Masri, R., & Delon, J. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00500-7 · Cited by 131
Actin Dynamics at the T Cell Synapse as Revealed by Immune-Related Actinopathies
Dupré, L., Boztug, K., & Pfajfer, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.665519 · Cited by 64
Kamnev, A., Lacouture, C., Fusaro, M., & Dupré, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.750537 · Cited by 38
“increased uropod length (17) Mice germinal centre B cells:”
BackgroundInfluential
Metadata
- Authors
- Bouafia, A., Lofek, S., Bruneau, J., Chentout, L., Lamrini, H., Trinquand, A., Deau, M.-C., Heurtier, L., Meignin, V., Picard, C., Macintyre, E., Alibeu, O., Bras, M., Molina, T. J., Cavazzana, M., André-Schmutz, I., Durandy, A., Fischer, A., Oksenhendler, E., & Kracker, S.
- Venue
- Journal of Clinical Investigation
- Published
- 2019-02-04
- Volume
- 129
- Issue
- 3
- Pages
- 1047-1060
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2902659083
- Cited by
- 54
- References
- 5
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Loss of ARHGEF1 causes a human primary antibody deficiency. https://app.cochat.ai/papers/10.1172/jci120572
- The paper
- Bouafia, A., Lofek, S., Bruneau, J., Chentout, L., Lamrini, H., Trinquand, A., Deau, M.-C., Heurtier, L., Meignin, V., Picard, C., Macintyre, E., Alibeu, O., Bras, M., Molina, T. J., Cavazzana, M., André-Schmutz, I., Durandy, A., Fischer, A., Oksenhendler, E., & Kracker, S. (2019). Loss of ARHGEF1 causes a human primary antibody deficiency. Journal of Clinical Investigation. https://doi.org/10.1172/jci120572
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.